PRR15

Across TCGA pan-cancer cohorts, PRR15 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated PRR15 data layer compared with 28 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher PRR15 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated PRR15 expression acts as an unfavorable survival marker.

COAD, ESCA, and ACC are the cancer types where PRR15 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.168	0.806	.002	24	view →
ESCA	DFS	Median	II,III,IV	0.163	0.525	.012	12	view →
ACC	DFS	Median	All	0.089	0.666	.017	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

PRR15–COAD (OS)

Open the COAD breakdown →